Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 17.20
+0.62 (3.74%)
Oct 21, 2026, 3:59 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 32.84 billion as of October 20, 2026. It is the 4,154th most valuable company in the world and the 208th biggest in Hong Kong. Its market cap has decreased by 16.32% in one year.
Market Cap
32.84B
Enterprise Value
35.50B
Revenue
3.49B
Global Rank
Country Rank
#208 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 32.84B, an increase of 81.84%. That is a compound annual growth rate of 7.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 32.84B | -5.26% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 76.21B |
| RemeGen | 54.97B |
| Biocytogen Pharmaceuticals (Beijing) | 37.86B |
| 3SBio | 36.64B |
| Shanghai Henlius Biotech | 28.52B |
| InnoCare Pharma | 26.42B |
| Keymed Biosciences | 25.51B |
| InSilico Medicine Cayman TopCo | 22.71B |